Answers are grounded in this paper and cite their sources.
Mycophenolate mofetil (MMF) is considered to be a promising therapeutic agent in primary glomerulonephritis but there are no data on the use of MMF in Henoch-Schönlein nephritis (HSN). Herein we report the first adult crescentic HSN patient in whom long-term complete remission was achieved after MMF therapy.
No takes yet. Share an insight, caveat, or question.
Dede et al. (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: